Description
+ Include: 19 videos + 1 pdf, size: 1.42 GB
+ Target Audience: oncologist, hematologist
+ Sample video: contact me for sample video
+ Topics:
AML – Debate Should MRD positivity guide therapy in non M3 AML – Con.mp4
AML – Debate Should MRD positivity guide therapy in non M3 AML – Pro.mp4
AML – Interactive Case Presentation-A case of FLT3 + AML.mp4
AML – State of the Art Navigating the Landscape of Best Frontline Therapies for AML in Older Adults.mp4
Lymphoid Malignancies – Debate Is CAR T cell therapy now the preferred second line therapy in relapsed refractory diffused large B cell lymphoma – Con.mp4
Lymphoid Malignancies – Debate Is CAR T cell therapy now the preferred second line therapy in relapsed refractory diffused large B cell lymphoma – Pro.mp4
Lymphoid Malignancies – Interactive Case PresentationMantle Cell Lymphoma.mp4
Lymphoid Malignancies – State of the Art Management of Follicular Lymphoma 1.mp4
Lymphoid Malignancies – State of the Art Management of Follicular Lymphoma 2.mp4
MDS MPN – Debate In Transplant-eligible patients with higher-risk MDS, should hypomethylating agents be implemented prior to transplant – Con.mp4
MDS MPN – Debate In Transplant-eligible patients with higher-risk MDS, should hypomethylating agents be implemented prior to transplant – Pro.mp4
MDS MPN – Interactive Case PresentationMDS MPN Overlap Syndrome.mp4
MDS MPN – State of the Art Using the Molecular Profiles in MDS to Guide Therapy.mp4
Multiple Myeloma CLL – Debate Is it Time for TimeLimited Therapy in CLL – Con.mp4
Multiple Myeloma CLL – Debate Is it Time for TimeLimited Therapy in CLL – Pro.mp4
Multiple Myeloma CLL – Interactive Case PresentationFrontline Refractory Multiple Myeloma Case 1.mp4
Multiple Myeloma CLL – Interactive Case PresentationFrontline Refractory Multiple Myeloma Case 2.mp4
Multiple Myeloma CLL – State of the Art in the Management of Multiple Myeloma 1.mp4
Multiple Myeloma CLL – State of the Art in the Management of Multiple Myeloma 2.mp4
Course Syllabus.pdf
Reviews
There are no reviews yet.